Germany's Novaliq Sets Up U.S. Subsidiary in Cambridge, Massachusetts
As an emerging leader in the field of ophthalmology, Novaliq is currently pursuing two late-stage clinical trials in the United States. Source: BioSpace
As an emerging leader in the field of ophthalmology, Novaliq is currently pursuing two late-stage clinical trials in the United States. Source: BioSpace
With headquarters located in San Diego, Calif. and Kalamazoo, Mich., Cirius Therapeutics is a clinical-stage pharmaceutical company focused on developing a treatment for NASH. Source: BioSpace
Adapsyn Bioscience today announced that it has completed a round of financing that was co-funded by Pfizer R&D Innovate and Genesys Capital. Source: BioSpace
Although the stock market seems to be moving up at the beginning of this year, the U.S. equities market appears more mixed, with healthcare stocks in particular appearing more volatile.…
The BTD decision for voxelotor was based on clinical data submitted from a trio of studies. Source: BioSpace
Gene therapy treatment is a high risk, high reward venture, but the promises of a therapy developed through these programs could be life-changing for patients. Source: BioSpace
Cellectar Biosciences is closing its manufacturing operations and contracting them out. Source: BioSpace
The transaction was led by Signet Healthcare Partners in addition to Crestline Investors with other investors comprised of Cane Investment Partners and existing Leading Pharma members. Source: BioSpace
Freenome, headquartered in South San Francisco, is focused on developing a diagnostic test for early detection of cancer and other diseases on the so-called "liquid biopsy," in other words, blood.…
The agreement validates Teva’s IP and resolves Alder’s opposition to Teva’s European Patent No. 1957106 B1. Source: BioSpace